Pono Capital Two Extends Outside Completion Date on SBC Medical Deal 8-K Filing SEC FilingApril 24, 2024
Read More Press Release SPAC IPO Orion Biotech Opportunities Prices $200M IPO The SPAC will target a company in the life sciences and biotechnology sectors.
Read More S-1 Filing SEC Filing Biotech Group Acquisition Pulls Plug on $75M IPO Biotech Group had planned to focus on the biotechnology sector in North America and the Asia-Pacific region (excluding China, Hong Kong and Macau).
Read More 8-K Filing SEC Filing BlueRiver Acquisition Postpones Extension Vote by a Week The SPAC wants to push its Aug. 2 deadline to Feb. 2, 2024. If approved and if management opts to run the extension until next February, it would mark more than three years since the SPAC’s IPO.
Read More SPAC IPO Newcourt Acquisition Prices Upsized $220M IPO The SPAC's focus is on digital financial services and fintech businesses with exposure to emerging markets.